Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 6/20 | 0.76 |
| ▸ | LMNA | P02545 | 4/20 | 0.76 |
| ▸ | HTT | P42858 | 4/20 | 0.76 |
| ▸ | TP53 | P04637 | 4/20 | 0.76 |
| ▸ | GAA | P10253 | 3/20 | 0.76 |
| ▸ | METAP2 | P50579 | 1/20 | 0.65 |
| ▸ | TERT | O14746 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 5/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | KCNMA1 | Q12791 | 2/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22851940 | 0.94 | LMNA (0.67) | NPC1LMNAHTTTP53GAA | |
| SCHEMBL12556433 | 0.91 | TERT (0.66) | NPC1LMNAHTTTP53GAA | |
| SCHEMBL22851942 | 0.87 | TERT (0.62) | NPC1LMNAHTTTP53GAA | |
| SCHEMBL29793770 | 0.87 | TERT (0.62) | NPC1LMNAHTTTP53GAA | |
| SCHEMBL845142 | 0.86 | LMNA (1.00) | NPC1LMNAHTTTP53GAA | |
| SCHEMBL22852280 | 0.86 | NPC1 (0.57) | NPC1LMNAHTTTP53GAA | |
| SCHEMBL7510268 | 0.86 | NPC1 (0.67) | NPC1LMNAHTTTP53GAA | |
| SCHEMBL28842312 | 0.85 | LMNA (0.96) | NPC1LMNAHTTTP53GAA | |
| SCHEMBL28842439 | 0.85 | LMNA (0.96) | NPC1LMNAHTTTP53GAA | |
| SCHEMBL10057829 | 0.83 | LMNA (0.64) | NPC1LMNAHTTTP53GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104886-A1 | METHOD FOR EXTRACTING LOW-MOLECULAR WEIGHT COLLAGEN USING POLLACK SKIN, LOW-MOLECULAR WEIGHT COLLAGEN, AND COSMETIC COMPOSITION COMPRISING SAME WITH SKIN REGENERATION EFFICACY | 유엔케이코리아 주식회사 | 2026-05-21 | — | — | WO | disclosed |
| US-12350352-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2025-07-08 | — | — | US | disclosed |
| EP-3342395-B1 | COMPOSITION FOR HAIR SURFACE MODIFICATION | LG HOUSEHOLD & HEALTH CARE LTD (KR) | 2024-08-07 | — | — | EP | disclosed |
| EP-4406617-A2 | COMPOSITION FOR SURFACE MODIFICATION | LG Household & Health Care Ltd. (KR) | 2024-07-31 | — | — | EP | disclosed |
| US-11612552-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. | 2023-03-28 | — | — | US | disclosed |
| US-20230088314-A1 | Composition For Surface Modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2023-03-23 | — | — | US | disclosed |
| WO-2022114681-A1 | CLEANSER COMPOSITION WITH ENHANCED ACTIVE SUBSTANCE DELIVERY | 주식회사 엘지생활건강 | 2022-06-02 | — | — | WO | disclosed |
| US-20200345599-A1 | Composition For Surface Modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2020-11-05 | — | — | US | disclosed |
| US-10799436-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2020-10-13 | — | — | US | disclosed |
| US-20180193236-A1 | COMPOSITION FOR SURFACE MODIFICATION | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2018-07-12 | — | — | US | disclosed |
| CN-107920973-A | Surface composition for modifying | 株式会社LG生活健康 | 2018-04-17 | — | — | CN | disclosed |
| EP-2617408-A2 | Two phase face cleaner with high ocular and mucous membrane compatibility | Henkel AG&Co. KGAA (DE) | 2013-07-24 | — | — | EP | disclosed |
| US-8067351-B2 | Composition with a color marker | COLGATE-PALMOLIVE COMPANY (US) | 2011-11-29 | — | — | US | disclosed |
| EP-2346476-A1 | COMPOSITION WITH A COLOR MARKER | Colgate-Palmolive Company (US) | 2011-07-27 | — | — | EP | disclosed |
| EP-2346477-A1 | COMPOSITION WITH A COLOR TO INDICATE COVERAGE | Colgate-Palmolive Company (US) | 2011-07-27 | — | — | EP | disclosed |
| US-20110021397-A1 | Composition With A Color Marker | COLGATE-PALMOLIVE COMPANY | 2011-01-27 | — | — | US | disclosed |
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | CIBA CORPORATION (US) | 2010-06-10 | — | — | US | disclosed |
| WO-2010056233-A1 | COMPOSITION WITH A COLOR TO INDICATE COVERAGE | COLGATE-PALMOLIVE COMPANY (US) | 2010-05-20 | — | — | WO | disclosed |
| WO-2010056232-A1 | COMPOSITION WITH A COLOR MARKER | COLGATE PALMOLIVE COMPANY (US) | 2010-05-20 | — | — | WO | disclosed |
| CN-101243042-A | Hydroxybenzamide derivatives, the method for preparing thereof and the cosmetic composition containing the same | AMOREPACIFIC CORP (KR) | 2008-08-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | MAOA, MAOB, ACMSD | NPC1 2036/4885LMNA 2164/4885HTT 1102/4885 |
| US-12350352-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | NPC1 4678/4885LMNA 2983/4885HTT 2832/4885 |
| US-20230088314-A1 | Composition For Surface Modification | CUTA, PTMS, DNMT1 | NPC1 4678/4885LMNA 2983/4885HTT 2832/4885 |
| US-11612552-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | NPC1 4678/4885LMNA 2983/4885HTT 2832/4885 |
| US-10799436-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | NPC1 4678/4885LMNA 2983/4885HTT 2832/4885 |
| US-20180193236-A1 | COMPOSITION FOR SURFACE MODIFICATION | CUTA, PTMS, DNMT1 | NPC1 4678/4885LMNA 2983/4885HTT 2832/4885 |
| US-20200345599-A1 | Composition For Surface Modification | CUTA, PTMS, DNMT1 | NPC1 4678/4885LMNA 2983/4885HTT 2832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.